BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31239633)

  • 1. Three-year outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic population with primary open-angle glaucoma.
    Gallardo MJ; Supnet RA
    Clin Ophthalmol; 2019; 13():869-879. PubMed ID: 31239633
    [No Abstract]   [Full Text] [Related]  

  • 2. Three-Year Outcomes of Second-generation Trabecular Micro-bypass Stents (iStent inject) With Phacoemulsification in Various Glaucoma Subtypes and Severities.
    Salimi A; Watt H; Harasymowycz P
    J Glaucoma; 2021 Mar; 30(3):266-275. PubMed ID: 33105306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter Effectiveness and Disease Stability Through 3 Years After iStentTrabecular Micro-Bypass with Phacoemulsification in Glaucoma and Ocular Hypertension.
    Clement C; Howes F; Ioannidis A; Shiu M; Manning D; Lusthaus JA; Skalicky SE; Goodwin TW
    Clin Ophthalmol; 2022; 16():2955-2968. PubMed ID: 36071724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective, Non-randomized, 36-Month Study of Second-Generation Trabecular Micro-Bypass Stents with Phacoemulsification in Eyes with Various Types of Glaucoma.
    Hengerer FH; Auffarth GU; Riffel C; Conrad-Hengerer I
    Ophthalmol Ther; 2018 Dec; 7(2):405-415. PubMed ID: 30430427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic patient population.
    Gallardo MJ; Supnet RA; Giamporcaro JE; Hornbeak DM
    Clin Ophthalmol; 2016; 10():1931-1937. PubMed ID: 27784981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-Year Outcomes of Second-Generation Trabecular Micro-Bypass Stents (iStent Inject) Implantation with Cataract Surgery in Different Glaucoma Subtypes and Severities.
    Salimi A; Lapointe J; Harasymowycz P
    Ophthalmol Ther; 2019 Dec; 8(4):563-575. PubMed ID: 31538316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study.
    Hengerer FH; Auffarth GU; Riffel C; Conrad-Hengerer I
    Adv Ther; 2019 Jul; 36(7):1606-1617. PubMed ID: 31119690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of two first-generation trabecular micro-bypass stents (iStent) with phacoemulsification in primary open-angle glaucoma: eight-year results.
    Salimi A; Watt H; Harasymowycz P
    Eye Vis (Lond); 2021 Nov; 8(1):43. PubMed ID: 34782017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-Year Multicenter Outcomes of iStent
    Clement C; Howes F; Ioannidis AS; Shiu M; Manning D; Lusthaus J; Lim R; Skalicky SE; Goodwin T
    Clin Ophthalmol; 2020; 14():3507-3517. PubMed ID: 33149544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iStent Trabecular Micro-Bypass Stent Implantation with Cataract Surgery in a Japanese Glaucoma Population.
    Nitta K; Yamada Y; Morokado S; Sugiyama K
    Clin Ophthalmol; 2020; 14():3381-3391. PubMed ID: 33116389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world Case Series of iStent or iStent inject Trabecular Micro-Bypass Stents Combined with Cataract Surgery.
    Manning D
    Ophthalmol Ther; 2019 Dec; 8(4):549-561. PubMed ID: 31422555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year outcomes following implantation of second-generation trabecular micro-bypass stents in conjunction with cataract surgery for various types of glaucoma or ocular hypertension: multicenter, multi-surgeon study.
    Clement CI; Howes F; Ioannidis AS; Shiu M; Manning D
    Clin Ophthalmol; 2019; 13():491-499. PubMed ID: 30936680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 12-Month Retrospective Comparison of Kahook Dual Blade Excisional Goniotomy with Istent Trabecular Bypass Device Implantation in Glaucomatous Eyes at the Time of Cataract Surgery.
    ElMallah MK; Seibold LK; Kahook MY; Williamson BK; Singh IP; Dorairaj SK;
    Adv Ther; 2019 Sep; 36(9):2515-2527. PubMed ID: 31317390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Outcomes of Combined 2nd-Generation Trabecular Microbypass (iStent Inject) and Cataract Surgery for the Treatment of Primary Open-Angle Glaucoma in the Saudi Population.
    Al Habash A; Otaif W
    Ophthalmol Ther; 2021 Dec; 10(4):923-933. PubMed ID: 34351592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-Year Comparative Evaluation of iStent or iStent inject Implantation Combined with Cataract Surgery in a Single Center.
    Guedes RAP; Gravina DM; Lake JC; Guedes VMP; Chaoubah A
    Adv Ther; 2019 Oct; 36(10):2797-2810. PubMed ID: 31440981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iStent inject Trabecular Micro-Bypass with or Without Cataract Surgery Yields Sustained 5-Year Glaucoma Control.
    Hengerer FH; Auffarth GU; Conrad-Hengerer I
    Adv Ther; 2022 Mar; 39(3):1417-1431. PubMed ID: 35113323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective Evaluation of Two iStent
    Myers JS; Masood I; Hornbeak DM; Belda JI; Auffarth G; Jünemann A; Giamporcaro JE; Martinez-de-la-Casa JM; Ahmed IIK; Voskanyan L; Katz LJ
    Adv Ther; 2018 Mar; 35(3):395-407. PubMed ID: 29476443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract: Two-Year Results.
    Samuelson TW; Sarkisian SR; Lubeck DM; Stiles MC; Duh YJ; Romo EA; Giamporcaro JE; Hornbeak DM; Katz LJ;
    Ophthalmology; 2019 Jun; 126(6):811-821. PubMed ID: 30880108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-Generation Trabecular Micro-Bypass (iStent inject) with Cataract Surgery in Eyes with Normal-Tension Glaucoma: One-Year Outcomes of a Multi-Centre Study.
    Salimi A; Clement C; Shiu M; Harasymowycz P
    Ophthalmol Ther; 2020 Sep; 9(3):585-596. PubMed ID: 32613589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of two trabecular micro-bypass stents combined with topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 3-year follow-up.
    Chang DF; Donnenfeld ED; Katz LJ; Voskanyan L; Ahmed II; Samuelson TW; Giamporcaro JE; Hornbeak DM; Solomon KD
    Clin Ophthalmol; 2017; 11():523-528. PubMed ID: 28352151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.